JP2703582B2 - 透析装置 - Google Patents

透析装置

Info

Publication number
JP2703582B2
JP2703582B2 JP63266265A JP26626588A JP2703582B2 JP 2703582 B2 JP2703582 B2 JP 2703582B2 JP 63266265 A JP63266265 A JP 63266265A JP 26626588 A JP26626588 A JP 26626588A JP 2703582 B2 JP2703582 B2 JP 2703582B2
Authority
JP
Japan
Prior art keywords
defibrotide
blood
dialysis
heparin
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63266265A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0292363A (ja
Inventor
レナート・ロツシ
Original Assignee
クリノス・インドウストリア・フアルマコビオロジカ・ソチエタ・ペル・アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クリノス・インドウストリア・フアルマコビオロジカ・ソチエタ・ペル・アチオニ filed Critical クリノス・インドウストリア・フアルマコビオロジカ・ソチエタ・ペル・アチオニ
Publication of JPH0292363A publication Critical patent/JPH0292363A/ja
Application granted granted Critical
Publication of JP2703582B2 publication Critical patent/JP2703582B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3672—Means preventing coagulation
    • A61M1/3675—Deactivation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP63266265A 1987-10-23 1988-10-24 透析装置 Expired - Lifetime JP2703582B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22399/87A IT1223322B (it) 1987-10-23 1987-10-23 Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT22399A/87 1987-10-23

Publications (2)

Publication Number Publication Date
JPH0292363A JPH0292363A (ja) 1990-04-03
JP2703582B2 true JP2703582B2 (ja) 1998-01-26

Family

ID=11195772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63266265A Expired - Lifetime JP2703582B2 (ja) 1987-10-23 1988-10-24 透析装置

Country Status (11)

Country Link
US (1) US4938873A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0317766B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2703582B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE83936T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU611495B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1313819C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3877154T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2037792T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3006730T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1223322B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT88830B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2034285A1 (en) * 1990-02-09 1991-08-10 Masao Yafuso Method and system for monitoring of blood constituents in vivo
US5286388A (en) * 1991-06-20 1994-02-15 Ingram John M Method for neutralizing heparin in whole blood taken from an extracorporeal circuit
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
US6153109A (en) 1994-09-16 2000-11-28 Transonic Systmes, Inc. Method and apparatus to measure blood flow rate in hemodialysis shunts
US6514419B2 (en) * 1994-09-16 2003-02-04 Transonic Systems, Inc. Method to measure blood flow and recirculation in hemodialysis shunts
US7670491B2 (en) * 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
ES2322689T3 (es) * 1999-09-22 2009-06-25 Advanced Renal Technologies Uso de un dializado con elevado contenido de citrato.
US6868739B1 (en) 1999-10-19 2005-03-22 Transonic Systems, Inc. Method and apparatus to measure blood flow by an introduced volume change
EP1147777A1 (en) * 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
US7351218B2 (en) 2002-12-20 2008-04-01 Gambro Lundia Ab Device and process for extracorporeal treatment by citrate anticoagulant
ITMO20030293A1 (it) 2003-10-29 2005-04-30 Gambro Lundia Ab Dispositivo per la determinazione del flusso di sangue in un circuito extracorporeo, nonche' apparecchiatura per il trattamento di sangue utilizzante lo stesso dispositivo.
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
BR112020002289A2 (pt) 2017-08-03 2020-07-28 Jazz Pharmaceuticals Ireland Limited formulações compreendendo um ácido nucleico em uma alta concentração
AU2019252790A1 (en) 2018-04-12 2020-10-15 Jazz Pharmaceuticals, Inc. Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
WO2021174039A1 (en) 2020-02-28 2021-09-02 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
EP4135717A1 (en) 2020-04-17 2023-02-22 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
US3946731A (en) * 1971-01-20 1976-03-30 Lichtenstein Eric Stefan Apparatus for extracorporeal treatment of blood
JPS5226076B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1972-10-06 1977-07-12
US3809481A (en) * 1972-12-01 1974-05-07 Nasa Single reflector interference spectrometer and drive system therefor
JPS5623961A (en) * 1979-08-07 1981-03-06 Kogyo Gijutsuin Portable artificial kidney apparatus
JPS58180163A (ja) * 1982-04-16 1983-10-21 日機装株式会社 血液浄化器における血球成分付着防止方法および装置
JPS59183763A (ja) * 1983-04-04 1984-10-18 第一電気株式会社 血液抗凝固剤使用減の血液透析方法および装置
JPS59197255A (ja) * 1983-04-22 1984-11-08 鐘淵化学工業株式会社 除去装置
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.

Also Published As

Publication number Publication date
PT88830B (pt) 1993-01-29
CA1313819C (en) 1993-02-23
DE3877154D1 (de) 1993-02-11
IT1223322B (it) 1990-09-19
ES2037792T3 (es) 1993-07-01
DE3877154T2 (de) 1993-04-29
ATE83936T1 (de) 1993-01-15
EP0317766A1 (en) 1989-05-31
US4938873A (en) 1990-07-03
IT8722399A0 (it) 1987-10-23
GR3006730T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-06-30
AU611495B2 (en) 1991-06-13
JPH0292363A (ja) 1990-04-03
AU2415888A (en) 1989-04-27
EP0317766B1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
JP2703582B2 (ja) 透析装置
Hirsh et al. Heparin kinetics in venous thrombosis and pulmonary embolism.
Bellomo et al. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study
Lohr et al. Minimizing hemorrhagic complications in dialysis patients.
US20080004225A1 (en) New dialysis method
Kobayashi et al. Antithrombotic therapy with ticlopidine in chronic renal failure patients on maintenance hemodialysis-A multicenter collaborative double blind study
Romao Jr et al. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
Aren et al. Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass
Henny et al. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis
Tyigate et al. Metabolism and Distribution of Fibrinogen 11. FIBRINOGEN TURNOVER IN POLYCYTHAEMIA, THROMBOCYTOSIS, HAEMOPHILIA A, CONGENITAL AFIBRINOGENAEMIA AND DURING STREPTOKINASE THERAPY
US20070275086A1 (en) Use of Increased Molecular-Weight Hirudin as an Anticoagulant in Extracorporeal Kidney Replace Therapy
Wright et al. Low thrombogenicity of polyethylene glycol–grafted cellulose membranes does not influence heparin requirements in hemodialysis
Novacek et al. Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin
Von Bonsdorff et al. A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis
Irani Antithrombin concentrates in heparin-resistant cardiopulmonary bypass patients
Heinrich et al. Prostacyclin in aortocoronary bypass surgery: A double-blind, placebo-controlled study
Ashouri Regional sodium citrate anticoagulation in patients with active bleeding undergoing hemodialysis
Winchester et al. Effect of sulphinpyrazone and aspirin on platelet adhesion to activated charcoal and dialysis membranes in vitro
Isgro et al. Topical application of aprotinin in cardiac surgery
KR20120022717A (ko) 피브리노겐의 신규 용도
Hamano et al. Beneficial effect of low molecular weight heparin on the hemodialysis model in dogs
Kreuzer et al. Anticoagulation in Children Undergoing Hemodialysis, Continuous Renal Replacement Therapy, or Apheresis Therapy
De Vos Anticoagulation therapy in acute renal failure extracorporeal treated patients
Olivet et al. The effects of ancrod anticoagulation on renal function in sheep
CA2369096A1 (en) Use of increased-molecular-weight hirudin as an anticoagulant in extracorporeal kidney replacement therapy